Search Results - "Reineck, T"

Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy by Uy, G L, Duncavage, E J, Chang, G S, Jacoby, M A, Miller, C A, Shao, J, Heath, S, Elliott, K, Reineck, T, Fulton, R S, Fronick, C C, O'Laughlin, M, Ganel, L, Abboud, C N, Cashen, A F, DiPersio, J F, Wilson, R K, Link, D C, Welch, J S, Ley, T J, Graubert, T A, Westervelt, P, Walter, M J

“…Traditional response criteria in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are based on bone marrow morphology and may not accurately…”
Get full text

A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia by Uy, G L, Rettig, M P, Stone, R M, Konopleva, M Y, Andreeff, M, McFarland, K, Shannon, W, Fletcher, T R, Reineck, T, Eades, W, Stockerl-Goldstein, K, Abboud, C N, Jacoby, M A, Westervelt, P, DiPersio, J F

Get full text

Phase I/II Study of Intravenous Plerixafor Added to a Mobilization Regimen of G-CSF in Lymphoma Patients Undergoing Autologous Stem Cell Collection by Cashen, A, Rettig, M, Gao, F, Reineck, T, Abboud, C, Stockerl-Goldstein, K, Vij, R, Uy, G, Westervelt, P, DiPersio, J

Get full text

Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia by Jacoby, Meagan A., Martin, Michael G., Uy, Geoffrey L., Westervelt, Peter, DiPersio, John F., Cashen, Amanda, Stockerl‐Goldstein, Keith, Vij, Ravi, Luo, Jingqin, Reineck, Teresa, Bernabe, Noel, Abboud, Camille N.

“…Clofarabine has shown activity and tolerability in older patients with acute myeloid leukemia (AML). We investigated the safety and tolerability of an oral…”
Get full text

Multidimensional outcomes in intravenous access device maintenance: a pilot study by Reineck, C, Reineck, Jr, T C

“…The nursing and pharmacology literature of 1988 to 1992 generally encouraged a change in nursing practice with regard to maintenance of peripheral intravenous…”
Get more information

Total hip replacement in patients younger than thirty years old. A five-year follow-up study by Chandler, H P, Reineck, F T, Wixson, R L, McCarthy, J C

Get full text